Condition (MeSH)
Hyperlipoproteinemia Type IV
ClinicalTrials.gov lists 9 trials for Hyperlipoproteinemia Type IV or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
9 of the 9 trials are tagged with Hyperlipoproteinemia Type IV itself; the rest are tagged with a narrower condition beneath it.
When did Hyperlipoproteinemia Type IV trials start? (9)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2024 | 1 |
| 2017 | 1 |
| 2016 | 1 |
| 2009 | 1 |
| 2007 | 1 |
| 2005 | 1 |
| 2004 | 1 |
| 2000 | 1 |
| 1993 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 9 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Hyperlipoproteinemia Type IV trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 2 |
| Phase 3 | 1 |
| Phase 4 | 2 |
| Not applicable | 2 |
| Observational | 2 |
How many Hyperlipoproteinemia Type IV trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Active, not recruiting | 1 |
| Completed | 6 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Hyperlipoproteinemia Type IV trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| AstraZeneca | 1 |
| GeneCradle Inc | 1 |
| Pfizer | 1 |
| Region Stockholm | 1 |
Which serious adverse events do Hyperlipoproteinemia Type IV trials report? (1)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Femur And Rotula Right Fracture That Required Hospitalization | 1 | 1 |
Which publications cover Hyperlipoproteinemia Type IV? (12)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Genome-wide scan for quantitative trait loci influencing LDL size and plasma triglyceride in familial hypertriglyceridemia. | Journal of lipid research | 2003 | Yes |
| Analysis of the ileal bile acid transporter gene, SLC10A2, in subjects with familial hypertriglyceridemia. | Arteriosclerosis, thrombosis, and vascular biology | 2001 | Yes |
| A genetic model for control of hypertriglyceridemia and apolipoprotein B levels in the Johns Hopkins colony of St. Thomas Hospital rabbits. | Genetics | 1992 | Yes |
| Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia. | Proceedings of the National Academy of Sciences of the United States of America | 1987 | Yes |
| Coronary artery disease mortality in relatives of hypertriglyceridemic school children: the Muscatine study. | Circulation | 1982 | Yes |
Showing 5 of 12 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.